Position in GILD
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$48,893
-$3,649 QoQ
Shares Held
387
+2.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2,065
of 2,266 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GoalVest Advisory LLC holds $8,839,620 across 11 Drug Manufacturers - General names. GILD ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,483 | $2,662,367 | |
| 2 | LLY |
ELI LILLY & Co
|
2,177 | $2,611,159 | |
| 3 | MRK |
Merck & Co., Inc.
|
13,375 | $1,718,687 | |
| 4 | ABBV |
AbbVie Inc.
|
6,577 | $1,655,036 | |
| 5 | AMGN |
Amgen Inc
|
195 | $70,613 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
387 | $48,893 | |
| 7 | BIIB |
Biogen Inc.
|
198 | $42,779 | |
| 8 | PFE |
Pfizer Inc
|
924 | $22,249 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,893 | 387 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $52,542 | 377 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $46,272 | 377 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $25,530 | 230 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $25,500 | 230 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $336 | 3 | Shares | Sole | 2025-04-07 | |
| 2023-12-31 | $11,341 | 140 | Shares | Sole | 2024-01-02 | |
| 2022-03-31 | $356 | 6 | Shares | Sole | 2022-05-03 | |
| No filing history on record for this holder in this stock. | ||||||